Revolution Medicines (RVMD) Net Margin (2019 - 2023)
Revolution Medicines (RVMD) reported Net Margin of -21770.49% for Q4 2023, down 21401.88 percentage points from -368.60% a year earlier.
Powered by 
Analysis
Revolution Medicines (RVMD) Net Margin (2019 - 2023) Analysis & Trends
For FY2023, Revolution Medicines posted Net Margin of -3768.28%, down 3065.33 percentage points from FY2022.
- Net Margin has declined for four consecutive years, with a five-year change of -3526.18 percentage points (FY2018 to FY2023).
- By year, Net Margin came in at -702.95% in FY2022 (-66.37 pp), -636.58% in FY2021 (-379.79 pp), -256.79% in FY2020 (-133.09 pp) and -123.70% in FY2019 (+118.40 pp).
- The Q4 2023 figure ranks as the lowest quarterly Net Margin in data going back to Q1 2019.
- Year over year, Net Margin gained in two of the last seven quarters, with an average year-over-year change of -3036.50 percentage points.
- The high point for year-over-year Net Margin in five years was Q3 2022 (a gain of 2623.34 percentage points); the low point was Q4 2023 (a drop of 21401.88 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | -1.65% |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -21,770.49% |
| Jun 30, 2023 | -2,570.55% |
| Mar 31, 2023 | -970.89% |
| Dec 31, 2022 | -368.60% |
| Sep 30, 2022 | -2,185.01% |
| Jun 30, 2022 | -671.59% |
| Mar 31, 2022 | -760.72% |
| Dec 31, 2021 | -556.83% |
| Sep 30, 2021 | -4,808.36% |
| Jun 30, 2021 | -509.30% |
| Mar 31, 2021 | -366.95% |
| Dec 31, 2020 | -390.86% |
| Sep 30, 2020 | -215.00% |
| Jun 30, 2020 | -271.47% |
| Mar 31, 2020 | -188.27% |
| Dec 31, 2019 | -155.91% |
| Sep 30, 2019 | -136.45% |
| Jun 30, 2019 | -107.34% |
| Mar 31, 2019 | -97.27% |
API Access
Revolution Medicines Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();